Anticoagulant therapy support for colorectal cancer patients with blood clots
Part of Heart & circulation clinical trials.
This trial tests whether a medication therapy management (MTM) model helps make blood thinner treatment safer and more effective for colorectal cancer patients who have also developed dangerous blood clots. It aims to improve how well patients stick to their medication and reduce complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have colorectal cancer and a confirmed blood clot (deep vein thrombosis or pulmonary embolism).
- You are currently taking or have taken blood thinners for your clot for at least 3 months.
- You are willing to continue active blood thinner treatment during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests two ways to prevent blood clots (deep vein thrombosis and pulmonary embolism) after colorectal cancer surgery. The study aims to find out if a new method is as good as the standard one, which could help reduce the risk of these serious complications.
This trial tests a new anticoagulant medication to treat and prevent blood clots in patients with active cancer. You may qualify if you have a recent clot in your leg or lungs and are already taking a blood thinner.
This trial tests whether continuing a lower dose of blood thinners can prevent another blood clot in cancer patients who have had a clot in an arm or chest catheter. It may help find a safer way to prevent future clots.
This study looks at how well blood thinners (anticoagulants) work in people with cancer who have had a blood clot. It aims to compare the benefits and risks of different anticoagulant medicines.
This trial is testing a program to help prevent blood clots in people with cancer who are starting a new type of cancer treatment, like chemotherapy or targeted therapy. The goal is to see if better prevention strategies can keep you safe during treatment.
This study looks at how people with cancer-related blood clots in the leg or lungs do with anticoagulant (blood thinner) treatment over at least 3 months. It also tracks quality of life and healthcare use, which may help improve supportive care for patients.
Hear when a new Thrombosis, Venous trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.